Pyxis Oncology Inc (PYXS) has gained 10.63% Monday In Premarket Trading

Pyxis Oncology Inc (PYXS) has gained Monday morning, with the stock climbing 10.63% in pre-market trading to 1.77. PYXS's short-term technical score of 61 indicates that the stock has traded more bullishly over the last month than 61% of stocks on the market. In the Biotechnology industry, which ranks 135 out of 146 industries, PYXS ranks higher than 84% of stocks. Pyxis Oncology Inc has fallen 25.93% over the past month, closing at $2.12 on August 28. During this period of time, the stock fell as low as $1.60 and as high as $2.46. PYXS has an average analyst recommendation of Strong Buy. The company has an average price target of $9.60.

PYXS has an Overall Score of 57. Find out what this means to you and get the rest of the rankings on PYXS!

See Full PYXS Report

Pyxis Oncology Inc has a Long-Term Technical rank of 21. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 79% of the market scoring higher. In the Biotechnology industry which is number 137 by this metric, PYXS ranks better than 137% of stocks.

Important Dates for Investors in PYXS:

-Pyxis Oncology Inc is set to release earnings on 2023-11-07. Over the last 12 months, the company has reported EPS of $-2.84. -We do not have a set dividend date for Pyxis Oncology Inc at this time. Click Here To Get The Full Report on Pyxis Oncology Inc (PYXS)